Webinar | June 13, 2022

Viral Safety Of Biologics: What's Changing With The ICH Q5A Revision?

ICH Q5A is currently being revised to address recent scientific advancements including novel therapeutic modalities, new manufacturing paradigms, updates in viral clearance applications, and alternate detection technologies. We'll discuss the expected changes and potential impact on viral safety strategies.

In this webinar, you will learn:

  • The Importance of virus testing in biologics products
  • Regulatory landscape, expectations for the Q5A revision
  • Examples of alternate testing schedules, impact on viral clearance
VIEW THE WEBINAR!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of BioProcess Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: